Magdalena Biosciences begins preclinical study of coca for appetite control Mar 16, 2026 09:00AM
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference Feb 6, 2025 10:00AM
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum Jan 7, 2025 10:00AM
Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications Dec 19, 2024 09:00AM
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum Oct 10, 2024 10:00AM


Aug 20, 2024 10:00AM Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
Aug 2, 2024 10:00AM Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Il
May 29, 2024 08:30AM Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Jan 30, 2024 08:45AM Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regi
Nov 15, 2023 08:55AM PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules
Nov 8, 2023 03:20PM Filament Health Announces Annual General Meeting Voting Results
Oct 30, 2023 08:30AM Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
Oct 23, 2023 08:30AM Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
Sep 21, 2023 07:30AM Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD
Apr 11, 2023 08:00AM PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules
Jan 23, 2023 08:30AM Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Jan 10, 2023 08:30AM Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses
Dec 15, 2022 08:47AM Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care
Sep 22, 2022 07:00AM Psyence Group Completes Export of Psilocybin Mushrooms to Canada
Jul 7, 2022 04:05PM Filament Health Announces First Dosing in Groundbreaking FDA-Approved Psilocin Clinical Trial
Jun 9, 2022 08:30AM Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications
May 31, 2022 09:00AM Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health
Apr 25, 2022 08:35AM Filament Health to Webcast Live at VirtualInvestorConferences.com April 28th
Apr 19, 2022 07:00AM Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products